The human hepatitis B virus (HBV) X protein (HBx) plays a crucial role(s) in the viral life cycle and contributes to the onset of hepatocellular carcinoma (HCC). HBx caused the mitochondrial translocation of Raf-1 kinase either alone or in the context of whole-viral-genome transfections. Mitochondrial translocation of Raf-1 is mediated by HBx-induced oxidative stress and was dependent upon the phosphorylation of Raf-1 at the serine 338/339 and Y 340/341 residues by p21-activated protein kinase 1 and Src kinase, respectively. These studies provide an insight into the mechanisms by which HBV induces intracellular events relevant to liver disease pathogenesis, including HCC.
Hepatitis B virus (HBV) infection results in a broad range of clinical symptoms, from mild, inapparent disease to fulminant hepatitis. Infection with this virus remains a major worldwide public health problem. It is estimated that there are about 500 million chronic carriers worldwide. Although the sequence of events remains poorly defined, a significant correlation has been made between long-term carriage of the virus and the development of hepatocellular carcinoma (4, 6) . Among the HBV proteins encoded by the four open reading frames (S, C, P, and X), the X protein (HBx) plays a crucial role in the pathogenesis of hepatocellular carcinoma (6, 17) . Like several viral oncoproteins, the HBx protein is implicated in a wide variety of cellular functions: as a trans-activator of transcription, in deregulation of cell cycle checkpoints, as a participant in the cellular signal transduction pathway, and in apoptosis (2, 6, 17) . HBx regulates a series of cell-signaling cascades involving most notably the Ras-and Raf-induced mitogen-activated protein kinase pathways (reviewed in reference 2).
The Raf serine/threonine kinases are involved in the Rasinduced mitogen-activated protein kinase pathway (1, 15) . They act downstream of Ras and are activated in a significant number of human malignancies (1, 15) . There are three isoforms of Raf, A-Raf, B-Raf, and C-Raf, each displaying distinct expression profiles (1, 13, 15) . C-Raf is ubiquitously expressed in many tissues, whereas A-Raf and B-Raf display tissue-specific expression (1, 15) . Only A-Raf and C-Raf have been shown to translocate to mitochondria and regulate apoptosis (1). C-Raf, also known as Raf-1, exists in the cytoplasm as a multiprotein complex of 300 to 500 kDa consisting of heat shock protein 90 and dimeric protein 14-3-3. Binding of Ras to Raf displaces the 14-3-3 complex and unmasks amino acid residues critical for its activation. Mitochondrially localized Raf-1 protects cells from stress-mediated apoptosis. Raf-1 contains a central activation domain whose phosphorylation is activated by p21-activated protein kinase (PAK) at amino acids Ser 338 and Ser 339 or Src kinase at amino acid residues Y 340 and Y 341 (5, 8) . B-Raf does not contain these tyrosine residues. The results of this study demonstrate that HBx can stimulate the mitochondrial translocation of Raf-1 via oxidative stress. We previously showed that HBx itself targets to mitochondria and directly interacts with voltage-dependent anion channel 3 (VDAC3) (7, 10, 11, 12) . HBx expression induces oxidative stress via calcium signaling and activates cellular kinases, which leads to the activation of transcription factors NF-B and STAT-3 and others via phosphorylation (2, 3, 14) . We observed that HBV-induced oxidative stress also stimulated the translocation of Raf-1 to mitochondria. This activation involves both the Src-and the PAK-mediated phosphorylation of the activation domain of Raf-1. Src inhibitors and dominantnegative PAK mutants abolished HBx-mediated Raf-1 mitochondrial translocation.
To demonstrate the role of HBx protein in regulating Raf-1 translocation, we first examined Raf-1 expression in Huh-7 cell lysates transfected with pCMVXF, which encodes the X gene placed under the transcriptional control of a cytomegalovirus (CMV) promoter containing a Flag sequence. The Western blot results show similar levels of Raf-1 expression in both untransfected and pCMVXF-transfected Huh-7 cellular lysates. (Fig. 1A) . We next examined the association of Raf-1 with mitochondria. The results of Western blot analysis of mitochondria prepared according to a detailed procedure (9) from Huh-7 and pCMVXF cells (presented in Fig. 1B ) demonstrate that both HBx protein and Raf-1 are associated with mitochondria. VDAC is used as a mitochondrial marker. To ensure that the Raf-1 and HBx signals were not due to cytoplasmic contamination, the lysates were also blotted for a cytoplasmic marker, lactate dehydrogenase (LDH). LDH expression was not observed in these mitochondrial preparations. The cytoplasmic fractions were also prepared and analyzed by a Western blot assay using anti-Raf, anti-Flag (which detects HBx), and anti-LDH (Fig. 1C) . Raf-1 kinase levels were again similar to those described for Fig. 1A , indicating that not all Raf-1 kinase translocates to mitochondria, consistent with previous studies (1, 15) . pCMVXF-transfected cellular lysates showed HBx expression, and LDH, used here as a cytoplasmic protein marker, was positive for both lysates. The vectors used thus far contained HBx under the transcriptional control of a CMV enhancer/promoter. To verify the role of HBx when expressed under the transcriptional control of the native promoter/enhancer in the context of the whole HBV genome, which recapitulates the viral life cycle, longer-than-genomelength HBV constructs were transfected into Huh-7 cells (6, 16) . Analysis of these cells showed Raf-1 mitochondrial translocation, whereas the whole-genome construct, defective in HBx expression, failed to induce mitochondrial translocation of Raf-1, as did the untransfected cells (Fig. 1D) . We further examined this phenomenon in transgenic mice harboring the HBx gene expressed under the control of its native promoter/ enhancer (16) . Mitochondria fractionated from liver tissues of HBx-transgenic mice were examined by a Western blot assay. As shown in Fig. 1D , Raf-1 also translocated to mitochondria in HBx-transgenic mice, as did HBx. This is the first report showing the association of the HBx with mitochondria in vivo using a transgenic-mouse model. We and others have previously shown that HBx targets to mitochondria using a variety of in vitro experimental strategies (7, 11, 12) . In normal mouse liver tissue, Raf-1 association with mitochondria was not observed (Fig. 1E) . These studies collectively provide evidence that HBx is associated with mitochondria and causes Raf-1 translocation to mitochondria both in cells transfected with HBx alone and in the context of the whole HBV genome. Moreover, a similar association was also seen in transgenic mice expressing HBx under the native promoter/enhancer (16) .
Mitochondrial translocation of Raf-1 requires phosphorylation of Ser and Tyr residues in its activation domain (5, 7). To (A) Raf-1 levels in untransfected and pCMVXF-transfected Huh-7 cellular lysates. Western blot analysis was carried out using anti-Raf-1 kinase antibody. Anti-actin was used as a protein loading control. (B) Mitochondrial preparations from untransfected and pCMVXFtransfected Huh-7 cells were used for Western blot analysis using anti-Raf-1 kinase antibody. VDAC serves as a mitochondrial marker. Anti-Flag was used to monitor HBx expression, and anti-LDH was used to monitor for cytoplasmic contamination. (C) Cytoplasmic fractions from untransfected and pCMVXF-transfected Huh-7 cells were analyzed by Western blot assays using anti-Raf-1, anti-Flag (which detects HBx), and anti-LDH. LDH is used here as a cytoplasmic marker. (D) Mitochondria were fractionated (9) from untransfected Huh-7 cells and cells transfected with whole-HBV-genome plasmids (HBV1.3L) and an X-defective mutant plasmid of the HBV genome [HBV1.3L (⌬X)] (gift from J. Ou, USC). Western blot analysis was carried out using anti-Raf-1 kinase antibody and anti-electron transport factor (anti-ETF; a mitochondrial marker) antibody. HBx protein expression was monitored by first immunoprecipitating with anti-HBx antibody (16), followed by immunoblotting with the same antiserum (16) . (E) Raf-1 mitochondrial translocation (9) in the HBx-transgenic mouse. Mitochondria were fractionated from normal and HBx-transgenic mice (gift from James Ou). HBx was expressed under its native promoter/enhancer (16) . Western blot analysis was performed on the mitochondrial preparation. Lane 1, normal mouse liver tissue; lane 2, HBx-transgenic mouse liver Western blots using anti-Raf-1. ETF is used as a mitochondrial marker. HBx expression in the HBx-transgenic mice was determined using anti-HBx antibody by immunoprecipitation (IP), followed by immunoblot analysis with the same antibody (gift from Betty Slagle) (16). residues, mitochondrial preparations from untransfected and pCMVXF-transfected Huh-7 cells were used for Western blot analysis using antiserum that recognizes Ser 338 residues of Raf-1. The results show that indeed HBx mediates the phosphorylation of Raf at Ser 338 residues ( Fig. 2A) . Serine phosphorylation of Raf-1 is catalyzed by PAK-1 (8) . Infection of untransfected and pCMVXF-transfected Huh-7 cells with a retrovirus encoding the autoinhibitory domain (PAK 83-149 ) of Pak-1 abrogated mitochondrial translocation of Raf-1, whereas in cells expressing HBx alone, Raf-1 migrated to mitochondria (Fig. 2B) . Tyrosine 340,341 phosphorylation of Raf-1 is known to be catalyzed by Src kinase (5). Huh-7 cells coexpressing HBx and dominant-negative Src kinase (kinase-dead pM5Hmet295; gift from Richard Jove [Moffat Cancer Center]) also failed to cause Raf-1 mitochondrial translocation (Fig. 2C) . Together, these results indicate that HBx must induce the activation of Src and Pak-1 kinases to phosphorylate Raf-1 at the Tyr and Ser residues, respectively, to trigger its mitochondrial translocation. HBx activates both Tyr and Ser/Thr kinases (reviewed in reference 2).
To examine whether HBx-induced reactive oxygen species play a role in the Raf-1 activation process, HBx (pCMVXF transfected)-expressing cells were treated with antioxidants Nacetyl cysteine and pyrrolidine dithiocarbamate. The results revealed that antioxidants prevented mitochondrial translocation of Raf-1 (Fig. 3) . Cells treated with calcium chelators (BAPTA-AM and TMB-8) did not interfere with Raf-1 mitochondrial translocation in either HBx or whole-HBV-genometransfected cells (data not shown). The role of Ca 2ϩ signaling needs to be further characterized.
Since both HBx and Raf-1 proteins are localized to mitochondria, we next investigated whether there is physical interaction between these proteins. Mitochondrial preparations from untransfected Huh-7 cells (Fig. 4A, lane 2 ) and those transfected with pCMVXF (Fig. 4A, lane 1) were immunoprecipitated with anti-Raf-1 antibody, followed by immunoblotting with anti-Flag antibody (Flag tagged to HBx). The presence of Raf-1 in the immunoblot indicated that Raf-1 and HBx formed a complex (Fig. 4A) . Expression of HBx-transfected cells is shown in Fig. 4B . Immunoprecipitation of lysates with an unrelated antibody (anti-HCV core) did not show any bands in the immunoblots (data not shown).
These studies collectively demonstrate the ability of HBx to induce the mitochondrial translocation of cytoplasmic Raf-1, and while resident in mitochondria, HBx forms a proteinprotein complex with Raf-1 kinase. The functional significance of this interaction may be that it reinforces the antiapoptotic program in infected hepatocytes. We previously noted the absence of cytochrome c release in HBx-expressing cells (unpublished results). Mitochondrial Raf-1 participates in the survival program (13) , but the exact mechanism behind the antiapoptotic role of Raf-1 remains to be investigated. HBx-activated Raf-1 may contribute to HBV-associated liver oncogenesis. 
